Quick Summary: As LAAO and other structural heart procedures grow, health systems need high-quality, accessible registry data to support NCDR LAAO Registry submissions, ACC accreditation, and strategic decision-making. The key to unlocking that value is a cardiovascular data management approach built on four capabilities: enterprise-level data access, transparency into data quality, actionable analytics, and exception reporting.
Structural heart care is changing rapidly. Advances in cardiovascular care are expanding treatment options, opening procedures to more patients, and creating new opportunities for health systems to grow their cardiovascular programs.
Left atrial appendage occlusion (LAAO) is a prime example. LAAO procedure volumes have increased significantly in recent years. As atrial fibrillation (AFib) becomes more prevalent—with an estimated 12 million people in the U.S. projected to have this condition by 2030—more patients may be evaluated for LAAO to reduce stroke risk. Meanwhile, the rise in transcatheter valve therapies and other procedures is expanding the role of these programs in cardiovascular care.
Registries like the NCDR LAAO Registry are a critical resource for monitoring patient care over time. By collecting and submitting data at the time of device implantation and at several follow-up intervals, participating hospitals can monitor patients beyond the initial procedure, ensure patients’ long-term safety, evaluate outcomes as time progresses, and build a clearer picture of how new treatments and devices perform in practice.
As LAAO and other structural heart programs grow, the value of this longitudinal data grows with them. Registry data does much more than support registry submission or meet compliance requirements. It’s an essential resource that offers valuable insights into program performance, quality improvement, and strategic decision-making.
To keep pace with these changes, health systems will need to rethink how they manage their structural heart registry data. With the right approach, that data can provide a clearer view of program performance, pinpoint opportunities to improve quality and outcomes, and inform decisions about future growth.
LAAO Growth Makes Data Quality More Important
As LAAO volumes increase, programs will have exponentially more data to draw on as they work to understand outcomes and identify trends. But the usefulness of that data hinges on its quality. Accurate and consistent abstraction is more important than ever. Because registry data follows patients beyond the initial procedure, it must be reliable enough to support lonitudinal monitoring and evaluation—not just registry submission today, but the decisions programs will make in the future.
This is especially important as newer areas of structural heart care develop. Clinical practices, technologies, and eligible patient populations can change over time. Having accessible, up-to-date cardiovascular data helps programs maintain visibility into those changes instead of relying on incomplete or inconsistent information. High-quality registry data also supports quality improvement and accreditation and certification efforts so that programs can continue to attract more patients and strengthen their reputation for cardiovascular excellence.
The Value of Making Registry Data Accessible and Actionable
Traditionally, much of the focus surrounding registry data has centered on the registry team and the requirements of accurate, complete submissions. While those requirements are important, they represent just part of the value this data can provide. As structural heart programs become more established, program leaders need information that can help them answer broader questions:
- How is the program performing?
- What opportunities are there to improve quality or outcomes?
- What do outcomes over time reveal about the long-term effectiveness and safety of the procedure?
- How does performance compare with other programs in the region?
- What does current performance suggest about future program needs?
Answering those questions requires accessible data. When data is siloed within departments or disparate platforms, its value stays limited. Clinical and quality leaders may struggle to get the insights they need when they need them, and executive stakeholders may lack a clear view of program performance and growth. To fully harness the value of their data, cardiovascular programs need a comprehensive platform that gives teams access to their data at an enterprise level.
The next step is making this data more actionable. As procedure volumes increase and treatment options advance, leaders need timely information to understand how they can best support their patient community’s evolving needs. Analytics capabilities offer powerful insight into broader trends in performance and outcomes. With the ability to monitor performance, create custom reports, and gain greater clarity from their data, leaders can determine where their programs stand and where new opportunities may exist.
Preparing for the Future of Structural Heart Care
The ability to turn data into timely, actionable insights depends on having the right foundation in place—and the tools necessary to draw meaning from it. High-quality data, accessible technology, and advanced analytics empower health systems to do exponentially more with their data. By establishing robust data quality processes and providing teams with secure, systemwide access to their data, cardiovascular programs can lay the groundwork for meaningful findings and more informed decision-making.
For health systems looking to get more value from their cardiovascular registry data, here are four capabilities worth prioritizing:
- Enterprise-level access to data. Data influences quality improvement, accreditation, reimbursements, and reputation, making it critical that the people responsible for those outcomes can access the information they need when they need it. Streamlining data access through a single platform ensures that clinical, quality, and executive leaders can more effectively use registry data to guide decisions and drive improvements.
- Transparency into data quality. Program leaders need to understand how their abstraction teams monitor and validate data quality. Having clear visibility into abstraction activity and quality metrics gives leaders greater confidence that their data is accurate, complete, and ready to support clinical and strategic decision-making.
- Actionable analytics. Intelligent analytics tools help cardiovascular leaders identify trends, benchmark performance, and understand where their programs have opportunities to improve and grow. By turning registry data into actionable insights, analytics tools help leaders evaluate performance over time and make more informed decisions about future growth.
- Exception reporting. Exception reporting tools that flag inconsistencies, missing documentation, and fallouts help teams resolve problems faster while reducing the manual effort required to find and report them.
Organizations that build a strong foundation now will be better equipped to enhance and grow their programs moving forward. As LAAO and other procedures continue to expand the possibilities for cardiovascular care, the programs that take steps to unlock the value of their data now will be better prepared to understand what’s currently working, respond to emerging patient needs, and plan for what comes next.
Explore how MRO helps health systems turn cardiovascular registry data into actionable insights for stronger programs and smarter decisions.
Frequently Asked Questions
What is LAAO and why is it growing?
LAAO (left atrial appendage occlusion) is a procedure used to reduce stroke risk in patients with atrial fibrillation (AFib). As AFib prevalence rises, with an estimated 12 million people in the U.S. projected to have the condition by 2030—more patients are being evaluated for LAAO, driving significant growth in procedure volumes.
Why is registry data quality important for structural heart programs?
Accurate, consistent registry abstraction ensures data is reliable enough to support NCDR LAAO Registry submissions today while also serving as a trustworthy foundation for quality improvement, ACC accreditation, and future program decisions.
What should health systems look for in a cardiovascular data management platform?
Four capabilities matter most: enterprise-level access so clinical, quality, and executive leaders can all use the data; transparency into how data quality is monitored; actionable analytics to benchmark performance and spot trends; and exception reporting to flag and resolve data issues efficiently.
What should health systems look for in a cardiovascular data management platform?
Beyond compliance, registry data helps leaders answer strategic questions—how the program is performing, where quality can improve, how it compares regionally, and what future needs to plan for—turning routine data collection into a driver of smarter, faster decisions.